360 High-Risk Vulnerability Immunization Tool V2.0 vs usbutils: Side-by-Side Comparison (2026)
Features, pricing, ratings, and pros & cons — compared head-to-head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). usbutils is a free endpoint protection platform tool. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack.
CST VerdictBased on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Linux infrastructure teams managing USB device inventory and access control will get the most from usbutils because it gives you direct, scriptable visibility into every connected device without agent overhead. The tool's 432 GitHub stars reflect active maintenance and widespread deployment in environments where USB enumeration and device querying are critical to compliance work. Skip this if you need graphical device management or centralized policy enforcement across mixed OS fleets; usbutils is strictly command-line utilities for Linux systems, not an endpoint protection platform in the traditional sense.
